Skip to main content

Reviva Pharmaceuticals Holdings, Inc DEF 14A, filed Nov 9, 2026

Reviva Pharmaceuticals Holdings, Inc. (RVPH)

DEF 14A 2026-11-09 For: 2026-12-18
View Original
Added on November 10, 2026

About this DEF 14A

Reviva Pharmaceuticals Holdings, Inc filed this DEF 14A on November 9, 2026.

At its December 18, 2026 meeting, Reviva Pharmaceuticals Holdings, Inc. will seek five director elections and approval of a reverse split from one-for-two (1:2) to one-for-one hundred (1:100). The board could implement it by December 31, 2027 without further approval. AI summary